Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients

ConclusionsHD patients had significantly stronger cellular and humoral immune responses than the control 3  weeks after the booster dose. Our findings will help in developing better COVID-19 vaccination strategies for HD and PD patients.

Source: Clinical and Experimental Nephrology - March 8, 2024 Category: Urology & Nephrology Source Type: research